The current target of gout treatment is to reduce levels down to 6 mg/dL or less. SEL-212 is based on a uricase enzyme (pegadricase) that breaks down uric acid in the blood combined with an immune ...
Gout tophi totally disappeared and renal function remained stable. The patient continues to receive rasburicase treatment. P Richette is a Rheumatologist and T Bardin is a Professor of ...
Gout is a painful form of inflammatory arthritis ... and heart and kidney diseases that can increase the chances it will occur. The goal of treatment is to reduce levels of uric acid in the ...
One of the treatment objectives in current guidelines is ‘cure’. However, audits show that only a minority of patients with gout receive adequate advice and treatment. Suboptimal care and outcomes ...